We are live on ! Find out more
HI

Humankind Investments Portfolio holdings

AUM $175M
1-Year Est. Return 14.3%
This Fund
S&P 500
This Quarter Est. Return
-6.1%
1 Year Est. Return
+14.3%
3 Year Est. Return
+46.43%
5 Year Est. Return
+54.92%
10 Year Est. Return
AUM
$207M
AUM Growth
-$1.7M
Cap. Flow
+$13.5M
Cap. Flow %
6.5%
Top 10 Hldgs %
65.33%
Holding
114
New
9
Increased
90
Reduced
6
Closed
4

Top Buys

Rank Stock Value
1
HKND
Humankind US Stock ETF
HKND
+$5.37M
2
VZ icon
Verizon
VZ
+$1.33M
3
BG icon
Bunge Global
BG
+$556K
4
PFE icon
Pfizer
PFE
+$521K
5
JNJ icon
Johnson & Johnson
JNJ
+$502K

Sector Composition

Rank Sector Weight
1 Healthcare 15.51%
2 Technology 13.67%
3 Consumer Staples 6.78%
4 Communication Services 5.17%
5 Materials 3.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECL icon
26
Ecolab
ECL
$79.9B
$1.27M 0.61%
8,780
+899
+11% +$146K
AWK icon
27
American Water Works
AWK
$26.9B
$1.25M 0.6%
9,608
+988
+11% +$149K
PEP icon
28
PepsiCo
PEP
$190B
$1.07M 0.52%
6,573
+556
+9% +$95.8K
AMGN icon
29
Amgen
AMGN
$222B
$1.05M 0.5%
4,646
+724
+18% +$175K
FMC icon
30
FMC
FMC
$1.33B
$1.04M 0.5%
9,887
+2,194
+29% +$237K
LH icon
31
Labcorp
LH
$25.9B
$977K 0.47%
5,553
+884
+19% +$181K
MDLZ icon
32
Mondelez International
MDLZ
$79.9B
$949K 0.46%
17,309
+2,081
+14% +$129K
WMT icon
33
Walmart Inc
WMT
$890B
$915K 0.44%
21,171
+1,005
+5% +$44K
MCK icon
34
McKesson
MCK
$101B
$867K 0.42%
2,551
+104
+4% +$36.1K
GILD icon
35
Gilead Sciences
GILD
$165B
$851K 0.41%
13,799
+1,971
+17% +$124K
DHR icon
36
Danaher
DHR
$144B
$840K 0.41%
3,667
+88
+2% +$21.5K
HCA icon
37
HCA Healthcare
HCA
$89.5B
$820K 0.4%
4,463
+543
+14% +$108K
T icon
38
AT&T
T
$163B
$797K 0.38%
51,946
+13,127
+34% +$239K
XYL icon
39
Xylem
XYL
$28.1B
$787K 0.38%
9,011
-168
-2% -$15.3K
WBA
40
DELISTED
Walgreens Boots Alliance
WBA
$779K 0.38%
24,804
+5,371
+28% +$199K
CF icon
41
CF Industries
CF
$17.3B
$768K 0.37%
7,984
+787
+11% +$76.8K
BIIB icon
42
Biogen
BIIB
$30.7B
$761K 0.37%
2,849
+282
+11% +$59.9K
REGN icon
43
Regeneron Pharmaceuticals
REGN
$80.8B
$736K 0.35%
1,069
+225
+27% +$142K
CVS icon
44
CVS Health
CVS
$122B
$728K 0.35%
7,631
+666
+10% +$65.9K
CMCSA icon
45
Comcast
CMCSA
$90B
$716K 0.35%
24,418
+5,790
+31% +$216K
CNC icon
46
Centene
CNC
$32.5B
$688K 0.33%
8,842
+341
+4% +$30.5K
CLX icon
47
Clorox
CLX
$12.7B
$686K 0.33%
5,341
+565
+12% +$81.5K
AMZN icon
48
Amazon
AMZN
$2.96T
$671K 0.32%
5,938
-422
-7% -$53.3K
TMO icon
49
Thermo Fisher Scientific
TMO
$220B
$671K 0.32%
1,322
+144
+12% +$80.6K
DELL icon
50
Dell
DELL
$293B
$666K 0.32%
19,477
-299
-2% -$12.6K

Similar funds

Humankind Investments's Q3 2022 Portfolio in Review

As of Q3 2022, Humankind Investments held 114 positions worth $207M, down 0.81% from $209M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Humankind Investments deployed $13.5M of net new capital in Q3 2022, opening 9 new positions and adding to 90 existing holdings. Its largest new stake was Universal Health Services: 2,498 shares worth $220K.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Apple, an estimated $174K trimmed.

  • Humankind Investments's largest Q3 2022 buy was Universal Health Services: 2,498 shares worth $220K.
  • Humankind Investments added most to Humankind US Stock ETF in Q3 2022, an estimated $5.37M increase.
  • Humankind Investments's biggest Q3 2022 reduction was Apple, cutting an estimated $174K.
  • Humankind Investments fully exited Vanguard FTSE Europe ETF in Q3 2022, selling an estimated $4.62M.
  • Humankind Investments's ten largest holdings make up 65% of its $207M portfolio in Q3 2022.
  • Humankind Investments opened 9 new positions and closed 4 in Q3 2022.
  • Humankind Investments's portfolio value fell 0.81% quarter-over-quarter to $207M.

Based on Humankind Investments's 13F filing for Q3 2022, filed 9 Nov 2022.